|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07D 401/04 | (2006.01) |
| C07D 471/04 | (2006.01) | ||
| C07D 487/04 | (2006.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/5025 | (2006.01) | ||
| A61P 5/26 | (2006.01) | ||
| A61P 5/28 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3124481 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16184263.8 |
| Date of filing the European patent application | 2011-02-16 | |
| (97) | Date of publication of the European application | 2017-02-01 |
| (45) | Date of publication and mention of the grant of the patent | 2018-03-28 |
| (46) | Date of publication of the claims translation | 2018-06-11 |
| (30) | Number | Date | Country code |
| 305082 P | 2010-02-16 | US | |
| 329023 P | 2010-04-28 | US | |
| 388457 P | 2010-09-30 | US |
| (72) |
Smith, Nicholas, D, US
Bonnefous, Celine, US
Julien, Jackaline, D., US
|
| (73) |
Aragon Pharmaceuticals, Inc.,
12780 El Camino Real, Suite 301, San Diego, CA 92130,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Androgeno receptorių moduliatoriai ir jų panaudojimas |
| ANDROGEN RECEPTOR MODULATORS AND USES THEREOF |
| Payment date | Validity (years) | Amount | |
| 2022-01-19 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-02-16 |